General
Preferred name
PALIPERIDONE
Synonyms
Ro-92670 ()
Invega Sustenna ()
9-hydroxyrisperidone ()
9-OH-risperidone ()
paliperidone ER, Torrent Pharmaceuticals ()
NSC-759623 ()
Ro-76477 ()
Invega ()
RO76477 ()
Risperidone impurity, 9-hydroxyrisperidone- ()
R-76477 ()
Xeplion ()
Trevicta ()
Paliperidone-d4 ()
P&D ID
PD009928
CAS
144598-75-4
130049-84-2
1020719-55-4
Tags
natural product
drug
available
Approved by
EMA
FDA
First approval
2006
Drug Status
approved
Drug indication
Schizophrenia
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PHARMACODYNAMICS Paliperidone is an atypical antipsychotic developed by Janssen Pharmaceutica. Chemically, paliperidone is primary active metabolite of the older antipsychotic risperidone (paliperidone is 9-hydroxyrisperidone). The mechanism of action is unknown but it is likely to act via a similar pathway to risperidone.
DESCRIPTION Paliperidone is an atypical antipsychotic. Mechanistically it is a dopamine receptor and 5-HT2A receptor antagonist. (GtoPdb)
DESCRIPTION 5-HT2C inverse agonist; alpha2-adrenoceptor antagonist (Tocris Bioactive Compound Library)
Compound Sets
25
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Enamine BioReference Compounds
Guide to Pharmacology
JUMP-Target 1 Compound Set
Ki Database
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NPC Screening Collection
Other bioactive compounds
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
External IDs
44
Properties
(calculated by RDKit )
Molecular Weight
426.21
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
1
Rotatable Bonds
4
Ring Count
5
Aromatic Ring Count
3
cLogP
3.08
TPSA
84.39
Fraction CSP3
0.52
Chiral centers
1.0
Largest ring
6.0
QED
0.69
QED
0.69
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
GPCR/G protein
Immunology/Inflammation
Neuroscience
Neuronal Signaling
Target
5-HT
??-adrenergic receptor
dopamine
H1 receptor
HTR2C
5-HT Receptor
Adrenergic Receptor
Dopamine Receptor
Primary Target
5-HT2A Receptors
MOA
Antagonist
VGSC Target
Nav1.5
Source data